Dow Down 0.92% Nasdaq Down 0.83%

Galectin Therapeutics, Inc. (GALT)

-NasdaqCM
4.76 0.33(6.48%) Oct 22, 4:00PM EDT
Prev Close:5.09
Open:5.08
Bid:4.56 x 200
Ask:6.50 x 100
1y Target Est:24.00
Beta:1.09
Next Earnings Date:N/A
Day's Range:4.70 - 5.08
52wk Range:4.28 - 19.11
Volume:84,136
Avg Vol (3m):676,008
Market Cap:104.92M
P/E (ttm):N/A
EPS (ttm):-0.82
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GALT

Comparison

Symbol% ChgMkt Cap
GALTDown 6.48%104.92M
MNTA548.82M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.03
Quarterly EPS Est (Sep-14) :-0.27
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Galectin Therapeutics Inc., a development stage company, is engaged in the research and development of therapies for fibrotic disease and cancer. The company’s lead product candidates include GR-MD-02, a complex polysaccharide polymer for the... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback